RecruitingNCT06183762

A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer

Real-World Treatment Patterns and Effectiveness of Targeted and Systemic Therapy in Patients With Advanced Lung Cancer Carrying MET Mutation-Positive


Sponsor

Hunan Province Tumor Hospital

Enrollment

200 participants

Start Date

Jan 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This is a descriptive observational study in which data are collected in an epidemiological manner. This study is not intended to alter or interfere with the current medical practice of the enrolled patients. Data will be collected in a forward-looking manner. This is a descriptive observational study in which data are collected in an epidemiological manner. This study is not intended to alter or interfere with the current medical practice of the enrolled patients. Data from patients on prior treatment will be collected retrospectively, and data from patients who will be treated later and included in the study will be collected in a prospective manner. The criteria for retrospective collection were consistent with those for prospective collection. Eligible patients will be enrolled after NGS analysis of tumor tissue and informed consent has been obtained. Information required for the study will be collected (every 3 months).


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patients must be ≥18 years of age.
  • Provision of fully informed consent prior to any study specific procedures.
  • Histologically or cytologically confirmed, unresectable stage IIIB/IIIC or stage IV NSCLC.
  • Genetic variants of tumor tissue detected by NGS.

Exclusion Criteria1

  • None.

Interventions

OTHERNo treatment is included in this protocol.

No drug intervention or tissue sampling will be included in this study.


Locations(1)

Hunan Province Tumor Hospital

Changsha, Hunan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06183762


Related Trials